
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>AbstractAbout 40% of schizophrenia patients report discrete visual disturbances which could occur if saccadic suppression, the decrease of visual sensitivity around saccade onset, is impaired. Two mechanisms contribute to saccadic suppression: efference copy processing and backwards masking. Both are reportedly altered in schizophrenia. However, saccadic suppression has not been investigated in schizophrenia. 17 schizophrenia patients and 18 healthy controls performed a saccadic suppression task using a Gabor stimulus with individually adjusted contrast, which was presented within an interval 300 ms around saccade onset. Visual disturbance scores were higher in patients than controls, but saccadic suppression strength and time course were similar in both groups with lower saccadic suppression rates being similarly related to smaller saccade amplitudes. Saccade amplitudes in the saccadic suppression task were reduced in patients, in contrast to unaltered amplitudes during a saccade control task. Notably, smaller saccade amplitudes were related to higher visual disturbances scores in patients. Saccadic suppression performance was unrelated to symptom expression and antipsychotic medication. Unaltered saccadic suppression in patients suggests sufficiently intact efference copy processing and backward masking as required for this task. Instead, visual disturbances in patients may be related to restricted saccadic amplitudes arising from cognitive load while completing a task.
Adult, Male, Science, 610 Medicine and health, 150, Vision Disorders, 610, perception and performance, Article, Contrast Sensitivity, 280121 - Expanding knowledge in psychology, Neuroscience; Psychiatric disorders, Saccades, Humans, info:eu-repo/classification/ddc/610, ddc:610, Psychotropic Drugs, Q, R, Middle Aged, 520406 - Sensory processes, Psychotic Disorders, Medicine and health, Schizophrenia, Visual Perception, Medicine, Female, Psychiatric disorders, Photic Stimulation, Neuroscience, ddc: ddc:610
Adult, Male, Science, 610 Medicine and health, 150, Vision Disorders, 610, perception and performance, Article, Contrast Sensitivity, 280121 - Expanding knowledge in psychology, Neuroscience; Psychiatric disorders, Saccades, Humans, info:eu-repo/classification/ddc/610, ddc:610, Psychotropic Drugs, Q, R, Middle Aged, 520406 - Sensory processes, Psychotic Disorders, Medicine and health, Schizophrenia, Visual Perception, Medicine, Female, Psychiatric disorders, Photic Stimulation, Neuroscience, ddc: ddc:610
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
